Daily non-political popular news in brief.
Drug-eluting and bare-metal stents equal in risk of blood clots, heart attacks and death
03-24-2007 · EurekAlert!Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit compared rates of complications in thousands of patients who received bare-metal stents (BMS) or DES.
Read more »
Keywords: drug-eluting, bare-metal, stents, equal, risk, blood, clots, heart, attacks, death, drug, eluting, bare, metal, stent, clot, attack
« Previous | Next »
Similar news on "Drug-eluting and bare-metal stents equal in risk of blood clots, heart attacks and death":
- SCAI issues clinical alert on drug-eluting stents and late thrombosis
01-11-2007 · EurekAlert!
The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert advising physicians on practical steps for reducing the risk of a rare but serious complication associated with drug-eluting stents. The document follows hearings held by the FDA's Circulatory Systems Device Panel. SCAI's clinical alert focuses on careful patient selection, meticulous stent implantation, and consistent use of medications to prevent the delayed formation of blood clots that can block blood flow to the heart.
Similar news · Read more »
- Patients who receive drug-eluting stents should continue antiplatelet medications
01-16-2007 · EurekAlert!
Patients who have had drug-eluting stents inserted to prop open blocked coronary arteries should continue to take medications to reduce the risk of blood clots for at least one year after the stent is inserted, a new scientific advisory recommends.
Similar news · Read more »
- Drug does not reduce risk of death for heart attack patients with refractory shock
03-26-2007 · EurekAlert!
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
Similar news · Read more »
- Risk and outcome similar for bypass surgery, drug-eluting stents
04-19-2007 · EurekAlert!
Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures, researchers reported at the American Heart Association's 8th annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.
Similar news · Read more »
- Second generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »
- Second-generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »
- Bare-metal stents are better for some heart patients
05-11-2007 · EurekAlert!
While drug-eluting stents are effective in keeping open diseased heart arteries, they should not be used for patients who need to have noncardiac surgery a short time after an interventional heart procedure. A presentation at the Society for Cardiovascular Angiography and Interventions in Orlando by cardiologists at Jefferson Medical College indicates that for these patients, bare metal stents provide a safer choice.
Similar news · Read more »
- High-dose anticlotting drug cuts heart attack, death risk in half
05-11-2007 · EurekAlert!
Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
Similar news · Read more »
- Common drug-releasing coronary stents appear to have similar clinical outcomes
01-29-2008 · EurekAlert!
A comparison of use of the first two commercially available drug-releasing coronary stents (for the medications sirolimus and paclitaxel) among patients in "everyday clinical practice" indicates no significant differences for outcomes such as heart attack or cardiac death, according to a study in the Jan. 30 issue of JAMA.
Similar news · Read more »
- Panic attacks associated with increased risk of cardiovascular events and death in older women
10-01-2007 · EurekAlert!
Older women who experience at least one full-blown panic attack may have an increased risk of having a heart attack or stroke and an increased risk of death in the next five years, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Similar news · Read more »
